Insider · CIK 0001978256
Versi Ebrahim
Reports to the SEC for 1 company · SAN DIEGO, CA
Transactions
10
Companies
1
Filings
2
CIK
0001978256
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2023-09-15 | DMK PHARMACEUTICALS CorpC Conversion | — |
| 2023-09-15 | DMK PHARMACEUTICALS CorpSeries E Convertible Preferred StockC Conversion | — |
| 2023-05-25 | DMK PHARMACEUTICALS CorpA Award | — |
| 2023-05-25 | DMK PHARMACEUTICALS CorpA Award | — |
| 2023-05-25 | DMK PHARMACEUTICALS CorpEmployee Stock Option (Right to Buy)A Award | — |
| 2023-05-25 | DMK PHARMACEUTICALS CorpEmployee Stock Option (Right to Buy)A Award | — |
| 2023-05-25 | DMK PHARMACEUTICALS CorpEmployee Stock Option (Right to Buy)A Award | — |
| 2023-05-25 | DMK PHARMACEUTICALS CorpEmployee Stock Option (Right to Buy)A Award | — |
| 2023-05-25 | DMK PHARMACEUTICALS CorpEmployee Stock Option (Right to Buy)A Award | — |
| 2023-05-25 | DMK PHARMACEUTICALS CorpSeries E Convertible Preferred StockA Award | — |
Recent filings
- 4Versi Ebrahim0001387131-23-011359SEC(opens sec.gov)
- 4Versi Ebrahim0001839882-23-013976SEC(opens sec.gov)
Companies
Address
C/O ADAMIS PHARMACEUTICALS CORPORATION 11682 EL CAMINO REAL, SUITE 300
SAN DIEGO, CA, 92130